High-power Laser Equipment

[INQ. NO. 2603E09] Founded in 1988, Union Medical Co., Ltd. is a medical device manufacturer specializing in the development and manufacture of various laser and energy-based medical devices, including electrosurgical devices and CO₂ lasers, using proprietary technology.
Union Medical continues to expand its global market by building a differentiated technology portfolio that includes 1450nm, 1550nm, and 1927nm lasers, multi-pulse IPL, pneumatic injection systems utilizing air, and high-frequency hyperthermia cancer-treatment devices.
To strengthen its quality competitiveness and to meet global standards, Union Medical has obtained ISO, GMP, and MDSAP certifications. Based on individual country-specific approvals, it is actively expanding into overseas markets.
In Korea, Union Medical has maintained steady sales based on its long-standing brand recognition and stable distribution network. In overseas markets, the company achieved record sales in 2025, demonstrating the success of its sales-channel diversification. In the Japanese market, in particular, the company has maintained stable performance, supplying over 100 CO₂ laser devices annually for over 20 years.
Union Medical recently showcased its key product lineup targeting the aesthetics and skincare markets, focusing on high-power laser equipment. Last year, it showcased the technological prowess of its existing products to both domestic medical professionals and international buyers.

Diode Laser Device
Union Medical’s flagship product, the NEOBEAM, is a 1450nm diode laser device characterized by its high absorption by water and sebum. With a high-output of 25W, it delivers consistent energy even through a 10mm lens, enabling deep energy penetration and shortening treatment times. Furthermore, the device features a cooling system to reduce the risk of burns and is designed with the safety of both users and patients in mind.

Dual Fractional Laser Device
Union Medical’s DE ORO DUAL is a dual fractional laser device that integrates two-wavelength lasers ― 1550nm and 1927nm ― into a single system. Designed to simultaneously target both epidermal and dermal lesions, its high output and small beam size maximize treatment effectiveness while minimizing side effects. Its flexibility in adapting to a variety of skin types and treatment objectives makes it a highly useful clinical device.
Union Medical is expanding its overseas business, targeting Japan and Brazil as key target markets. In Japan, the company is expanding its product line with a variety of laser devices, leveraging its experience in selling CO₂ lasers. It also plans to strengthen its presence among medical professionals through participation in relevant academic conferences. In Brazil, considering the high demand for skincare products, the company is establishing a bridgehead for full-scale market entry based on its MDSAP certification.
Going forward, Union Medical plans to respond to the rapidly evolving demands of the aesthetic medicine market through continued investment in R&D, and to expand its reach to global buyers by participating in key international academic conferences and exhibitions, such as IMCAS, DUBAI DERMA, and AMWC. In 2026, it plans to introduce differentiated new products that reflect customer needs and further strengthen its competitiveness in the laser-based aesthetic medical device market. 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods